## Management of Multiple Fibroadenomas ### Clinical Context **Key Point:** Multiple fibroadenomas (fibroadenomatosis) are benign lesions that do NOT increase cancer risk and do NOT require prophylactic excision. The diagnosis is secure when imaging shows typical benign features (BI-RADS 2–3). ### Management Algorithm for Benign Breast Lesions ```mermaid flowchart TD A[Multiple breast nodules]:::outcome --> B{Imaging features benign?}:::decision B -->|Yes, BI-RADS 2-3| C[Diagnosis: Fibroadenoma/Benign]:::outcome B -->|No, suspicious| D[Biopsy indicated]:::action C --> E{Patient anxious or rapid growth?}:::decision E -->|No| F[Reassurance + Surveillance]:::action E -->|Yes| G[Excision for reassurance]:::action F --> H[Clinical exam every 6 months]:::action H --> I[Imaging if change noted]:::action ``` ### Why Observation is Safe | Aspect | Evidence | |--------|----------| | **Malignant transformation** | 0% — fibroadenomas are benign and do NOT transform to cancer | | **Cancer risk increase** | No increased risk compared to general population | | **Natural history** | Many remain stable or regress; growth is slow | | **Imaging surveillance** | BI-RADS 2 lesions require no follow-up; BI-RADS 3 requires imaging at 6 months | **High-Yield:** Fibroadenomas are **NOT** a risk factor for breast cancer. The presence of multiple fibroadenomas does NOT elevate cancer risk. ### Indications for Excision **Clinical Pearl:** Excision is indicated for: 1. **Diagnostic uncertainty** — atypical features on imaging or biopsy 2. **Rapid growth** — > 25% increase in size over 6 months 3. **Patient anxiety** — after counselling and reassurance 4. **Cosmetic concerns** — if lesions are large or disfiguring 5. **Giant fibroadenoma** — > 5 cm ### Why Other Options Are Inappropriate **Warning:** Bilateral mastectomy for benign fibroadenomas is **NOT justified** and represents over-treatment. Fibroadenomas carry zero malignant potential. ### Counselling Points 1. **Reassurance** — fibroadenomas are benign and will not become cancer 2. **Natural history** — many remain stable or shrink after menopause 3. **Surveillance** — clinical examination every 6 months; imaging only if change is noted 4. **Excision** — optional, offered only for diagnostic uncertainty, rapid growth, or patient preference **Mnemonic: FIBROADENOMA SURVEILLANCE = **F**irm diagnosis on imaging, **I**ntervention only if uncertain, **B**enign always, **R**eassure patient, **O**bservation safe, **A**void over-treatment, **D**ynamic imaging only if change, **E**xcision optional, **N**o cancer risk, **O**ne exam per 6 months, **M**alignant potential zero, **A**ge-appropriate follow-up** 
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.